2022
DOI: 10.14710/jksa.25.3.123-129
|View full text |Cite
|
Sign up to set email alerts
|

Potential of C-Phenylcalix[4]Resorcinarene Epoxide Compound as Drug Delivery Agent in Breast Cancer Cells MCF-7

Abstract: Cancer therapy through conventional chemotherapy has been widely applied; however, one of the main disadvantages of chemotherapy is the non-selective targeting of cancer cells which causes various adverse side effects. The development of drug delivery agents that are more selective and effective in cancer therapy needs to be performed so that the drugs have a therapeutic effect and minimize side effects. In this study, the compound C-phenylcalyx[4]resorcinarene epoxide (CFKRE) has acted as a drug delivery agen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…Efforts to reduce the side effects caused by the active ingredients of drugs that are more selective and effective in cancer treatment are needed (Fatmawati et al, 2022). Modern computational chemistry approaches using molecular docking methods can simulate how compounds interact with target proteins and predict the chemical characteristics required for drug activity (Widiyarti, Firdayani, et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…Efforts to reduce the side effects caused by the active ingredients of drugs that are more selective and effective in cancer treatment are needed (Fatmawati et al, 2022). Modern computational chemistry approaches using molecular docking methods can simulate how compounds interact with target proteins and predict the chemical characteristics required for drug activity (Widiyarti, Firdayani, et al, 2019).…”
Section: Introductionmentioning
confidence: 99%